NeoGenomics NEO Reportable Segment — Income tax expense (benefit)

Similar metrics at other companies

LOGIReportable Segment — Income Tax Expense (Benefit)

$6.39M—

ELANReportable Segment — Income tax expense (benefit)

$30M+529%

FOURReportable Segment — Income Tax Expense (Benefit)

-$24M-167%

ZVRAReportable Segment — Income Tax Expense (Benefit)

-$6.91M-485%

RXRXReportable Segment — Income Tax Expense (Benefit)

-$4.6M-2,814%

SHAKReportable Segment — Income tax expense (benefit)

-$145K-120%

Questions, answered.

What is NeoGenomics's reportable segment — income tax expense (benefit)?

NeoGenomics (NEO) reported reportable segment — income tax expense (benefit) of -$472K in Q1 2026.

How has NeoGenomics's reportable segment — income tax expense (benefit) changed year-over-year?

NeoGenomics's reportable segment — income tax expense (benefit) decreased by 277.4% year-over-year, from $266K to -$472K.

What is the long-term trend for NeoGenomics's reportable segment — income tax expense (benefit)?

Over 3 years (2022 to 2025), NeoGenomics's reportable segment — income tax expense (benefit) has grown at a -47.0% compound annual growth rate (CAGR), from -$15.09M to -$2.24M.

What does reportable segment — income tax expense (benefit) mean?

This represents the tax provision or benefit allocated to the reportable segment based on its pre-tax earnings or losses. It reflects the impact of statutory tax rates and tax planning strategies on the segment's bottom-line performance.